GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Long-Term Debt

Curocell (XKRX:372320) Long-Term Debt : ₩31,283.60 Mil (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Long-Term Debt?

Curocell's Long-Term Debt for the quarter that ended in Jun. 2023 was ₩31,283.60 Mil.

Curocell's quarterly Long-Term Debt increased from Jun. 2022 (₩0.00 Mil) to Dec. 2022 (₩26,085.00 Mil) and increased from Dec. 2022 (₩26,085.00 Mil) to Jun. 2023 (₩31,283.60 Mil).

Curocell's annual Long-Term Debt increased from Dec. 2021 (₩6,607.00 Mil) to Dec. 2022 (₩26,085.00 Mil) and increased from Dec. 2022 (₩26,085.00 Mil) to Dec. 2023 (₩39,595.01 Mil).

Curocell Long-Term Debt Historical Data

The historical data trend for Curocell's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Long-Term Debt Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
- - 6,607.00 26,085.00 39,595.01

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Long-Term Debt - 26,085.00 31,283.60 39,595.01

Curocell  (XKRX:372320) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Curocell Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Curocell's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Curocell (XKRX:372320) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Long-Term Debt
Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Website
https://www.curocellbtx.com
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines